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Purpose: Leber congenital amaurosis (LCA) is one of the most severe eye dystrophies characterized by severe vision loss
at an early stage and accounts for approximately 5% of all retinal dystrophies. The purpose of this study was to identify
a novel LCA disease allele or gene and to develop an approach combining genetic mapping with whole exome sequencing.
Methods: Three patients from King Khaled Eye Specialist Hospital (KKESH205) underwent whole genome single
nucleotide polymorphism genotyping, and a single candidate region was identified. Taking advantage of next-generation
high-throughput  DNA  sequencing  technologies,  whole  exome  capture  sequencing  was  performed  on  patient
KKESH205#7. Sanger direct sequencing was used during the validation step. The zebrafish model was used to examine
the function of the mutant allele.
Results: A novel missense mutation in Bardet-Biedl syndrome 4 protein (BBS4) was identified in a consanguineous family
from Saudi Arabia. This missense mutation in the fifth exon (c.253G>C;p.E85Q) of BBS4 is likely a disease-causing
mutation as it segregates with the disease. The mutation is not found in the single nucleotide polymorphism (SNP) database,
the 1000 Genomes Project, or matching normal controls. Functional analysis of this mutation in zebrafish indicates that
the G253C allele is pathogenic. Coinjection of the G253C allele cannot rescue the mislocalization of rhodopsin in the
retina when BBS4 is knocked down by morpholino injection. Immunofluorescence analysis in cell culture shows that this
missense mutation in BBS4 does not cause obvious defects in protein expression or pericentriolar localization.
Conclusions: This mutation likely mainly reduces or abolishes BBS4 function in the retina. Further studies of this allele
will provide important insights concerning the pleiotropic nature of BBS4 function.
The molecular mechanisms underlying genetic diseases
are often highly heterogeneous. Specifically, mutations in
different genes can result in the same clinical phenotype. In
addition, patients with different mutations, or even the same
mutation,  in  one  gene  can  manifest  different  clinical
phenotypes.  This  underscores  the  importance  of
comprehensive documentation of phenotype and genotype
relationships as the first step in accurate and personalized
treatment of the disease. Leber congenital amaurosis (LCA;
OMIM 204000) most often presents as a recessive disease, is
one of the most severe forms of vision loss, is apparent by 1
year of age, and accounts for more than 5% of all retinal
dystrophies  [1,2].  The  clinical  features  of  this  genetically
heterogeneous disease include severe and early visual loss,
sensory nystagmus, amaurotic pupils, and absent electrical
signals on electroretinogram (ERG) [1,3]. To date, at least 15
genes  have  been  associated  with  LCA,  and  they  act  in
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strikingly diverse genetic and functional pathways, including
retina  development,  phototransduction,  vitamin  A
metabolism,  protein  transport,  and  centrosome  formation
[4-11]. As a result, accurate molecular diagnosis of the disease
is essential for developing and providing proper treatment to
the patient. Indeed, gene and drug therapy have recently been
developed specifically for patients with mutations in retinal
pigment epithelium 65 (RPE65) [12,13].
Despite the substantial efforts in human mapping studies
during the last decade, about 35% of LCA familial cases in
the  European  population  cannot  be  accounted  for  by
mutations in the 15 known LCA genes. The portion of LCA
patients with unknown mutations in other populations may be
significantly  higher  [7,14].  These  cases  can  be  partially
explained by novel LCA disease genes. Gene identification
becomes increasingly difficult as each likely accounts for only
a small fraction of the patients with this rare disease. Some of
these patients may carry mutations in other known retinal
disease genes not been previously linked to LCA. This is
particularly  likely  for  genes  normally  associated  with
syndromic retinal degenerative diseases. Indeed, researchers
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3529have  reported  that  several  syndromic  diseases,  such  as
Alström syndrome, Batten disease, Joubert syndrome (JBTS),
peroxisomal diseases, and Senior-Loken syndrome (SLSN),
show an “LCA-like ocular phenotype” [6]. The mutations in
some known LCA disease genes can also cause syndromic
diseases.  For  example,  Centrosomal  protein  of  290  kDa
(CEP290, also known as NPHP6), which represents the most
common cause of LCA identified to date [15,16], is also
associated with other diseases, such as retinitis pigmentosa
[17], Meckel syndrome (MKS) [18,19], SLSN [20], Bardet-
Biedl  syndrome  (BBS)  [21]  and  JBTS  [22,23].  Similarly,
Bardet–Biedl syndrome protein-8 (BBS8), one of the genes
involved  in  BBS,  has  been  linked  to  retinitis  pigmentosa
[24].
Since more than 165 genes have been associated with
retinal diseases (RetNet), screening for mutations in all of
these  genes  with  traditional  Sanger  sequencing  is  cost
prohibitive.  The  recent  development  of  next-generation
sequencing technology provides a much faster and more cost-
effective  alternate  approach  for  identifying  causative
mutations  [25-28].  For  example,  the  entire  exome  of  an
individual can be sequenced at great depth with a single lane
of the Illumina HiSeq 2000 sequencer coupled with DNA
capture technology [29-32]. Indeed, several disease-causing
mutations have been identified with exome sequencing of a
small number of patients, underscoring the great potential of
this technology [33-41].
To  test  the  feasibility  of  identifying  disease-causing
mutations  with  direct  sequencing,  we  employed  a
combination  of  genetic  mapping  and  the  whole  exome
sequencing  approach.  Based  on  single  nucleotide
polymorphism (SNP) mapping, we first mapped the disease
locus of a Saudi family to an 11.2 Mb region on chromosome
15. With whole exome capture and sequencing, we identified
a missense mutation in BBS4 (NM_033028), one of the 14
genes  known  to  cause  BBS  (OMIM  209900)  [42].  This
mutation was further confirmed with Sanger sequencing and
family segregation. Bbs4- zebrafish was used to determine the
functional relevance of this allele. In contrast, the mutant
BBS4  mRNA  with  the  missense  allele  cannot  rescue  the
gastrulation and the retinal phenotype, while the wild-type
human BBS4 mRNA can successfully rescue the gastrulation
and the retinal phenotype. Our results are the first report that
links BBS4 with LCA and indicates that partial loss of BBS4
function can cause an LCA-like phenotype with quite mild
syndromic features.
METHODS
Subjects: The study was approved by the Human Subjects
Ethics Subcommittee of Baylor College of Medicine. We
obtained  blood  samples  and  pedigrees  after  receiving
informed consent from all individuals. Approval was obtained
from  the  institutional  review  boards  of  the  participating
centers.  Family  KKESH205  was  recruited  by  Dr.  Lewis
through the King Khaled Eye Specialist Hospital (KKESH)
in Riyadh, Saudi Arabia. Blood samples from all available
family members were collected and processed at KKESH
hospital  in  Riyadh,  Saudi  Arabia  with  the  Qiagen
(Germantown,  MD)  blood  genomic  DNA  extraction  kit
following the protocol provided by the manufacturer.
Whole exome capture and library construction: Five μg of
genomic  DNA  from  KKESH205#7  was  used  to  make  a
SOLiD  fragment  library.  After  the  SOLiD  adaptors  were
ligated to the genomic DNA, five cycles of PCR amplification
were  applied.  This  DNA  was  then  hybridized  to
oligonucleotides  from  NimbleGen’s  (Madison,  WI)  liquid
capture kit (the Consensus CDS design design) for 72 h to
enrich exonic regions. Hybridized fragments were eluted and
sequenced with single end 50 bp reads on a SOLiD platform.
Sanger  sequencing:  Primers  surrounding  the  variant  were
designed with the online program Primer3, and PCR products
were purified with ExoSAP-IT (USB Corp, Cleveland, OH).
Sequencing chemistry was performed using an ABI (Life
Technology,  Carlsbad,  CA)  PRISM  Big  Dye  Terminator
Cycle  Sequencing  Ready  Reaction  Kit  (v3.1),  the  PCR
amplicon sequenced on an ABI 3700, and the results analyzed
using Sequencher software.
Morpholino  knockdown:  Wild-type  zebrafish  of  an  AB/
Ekkwill hybrid strain were housed, bred, and staged according
to standard procedures [43]. Wild-type embryos (n=280–300)
were injected at the 1–2 cell stage with 4.0 ng of a bbs4
morpholino (GeneTools, Philomath, OR) designed to block
translation of bbs4 mRNA (5′-GAA AAA GAT CAC TAC
TGT AAA GCA T-3′). To quantify our results, we used a
classification  scheme  similar  to  one  previously  described
[44].  Embryos  with  normal  somites  and  notochord  but  a
shortened body axis were considered mild, whereas embryos
with broad, flattened somites and severely kinked notochords
were considered severe.
Immunohistochemistry:  Larvae  were  fixed  in  4%
paraformaldehyde in PBS (137 mM NaCl, 10 mM phosphate,
2.7 mM KCl, pH 7.4) for 2–4 h at 4 °C. Following fixation,
samples were washed in PBST (PBS + 0.01% Tween-20) and
equilibrated with 30% sucrose/PBS at 4 °C. Samples were
oriented in 100% Tissue-Tek OCT (Miles, Inc., Elkhart, IN)
and  frozen  at  −20  °C.  Cryosections  (10  μm  thick)  were
mounted on gelatin-coated slides, and dried for 2–3 h at room
temperature.  Slide  edges  were  lined  with  a  hydrophobic
marker (PAP pen) and washed with PBS before blocking for
1 h (PBS + 0.05% Tween-20 + 0.1% dimethyl sulfoxide +
0.1% BSA). The 1D1 antibody (gift of Dr. James Fadool,
Florida State University, Tallahassee, FL) was diluted 1:100
in blocking solution and incubated overnight at 4 °C in a
humid  chamber.  Slides  were  washed  with  PBST  before
incubation  with  the  appropriate  fluorescent-conjugated
secondary antibodies. Slides were counterstained with 4',6-
diamidino-2-phenylindole (DAPI; Invitrogen, Carlsbad, CA)
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and coverslips were mounted with Vectashield (Invitrogen).
Images  were  obtained  using  a  Zeiss  AxioImager  (Zeiss,
Thornwood, NY) compound microscope with an ApoTome
attached.
RNA synthesis: The wild-type and mutant BBS4 alleles were
amplified with PCR and cloned into pBluescript (Fermentas,
Inc., Glen Burnie, MD). The plasmids were linearized with
BamH1,  purified,  and  used  as  a  template  for  in  vitro
transcription  to  generate  5′-capped  mRNAs  with  the
mMESSAGE  mMACHINE  kit  (Ambion,  Austin,  TX).
Synthetic  mRNA  (150–300  pg)  was  injected  alone  or
coinjected with morpholinos.
In  situ  hybridization:  Digoxigenin-labeled  antisense
riboprobes were synthesized from full-length cDNAs using
standard protocols. The pax2.1 and myoD full length cDNAs
were gifts from Dr. Arne Lekven (Texas A&M University,
College Station, TX). In situ hybridizations were performed
as previously described [45].
Cell transfection: HeLa cells were transfected with 1 µg of
pCmv-BBS4 cDNA and used for immunostaining 24 h later.
HeLa cells were fixed with methanol/acetone (1:1) at room
temperature  for  10  min  and  blocked  with  PBS-10%  fetal
bovine serum (FBS) for 10 min before primary antibody was
added.  Primary  antibodies  (mouse  anti-FLAG  1:100  and
rabbit antigamma-tubulin, Sigma, St. Louis, MO) in PBS-5%
FBS were incubated with the cells at 37 °C for 2 h, followed
by  washing.  The  cells  were  incubated  with  secondary
antibodies  (Annexin  V-antimouse,  Cy3-antirabbit)  in
PBS-5% FBS (1:1,000) at 37 °C for 1 h. The cells were
washed, DAPI stained, and mounted.
Bioinformatic  analyses:  To  analyze  the  large  amount  of
exome  sequencing  data,  a  semiautomated  pipeline  was
constructed to identify putative disease-causing mutations.
First, all reads were mapped to the human reference genome
(NCBI  build  36)  using  BWA  (Ver.  0.5.0)  with  default
parameters [46]. Reads that mapped to multiple positions in
the genome were excluded from further analysis. Second,
putative  variants,  including  single  nucleotide  variants  or
insertions  or  deletions  (in/dels),  were  identified  using
Samtools [47]. A cutoff score of 40 or variance bases at both
strands with a confidence score greater than 30 were used to
exclude low-quality variants. Furthermore, only variants with
allele frequencies greater than 15% were kept.
RESULTS
Clinical  features:  KKESH205  is  a  consanguineous  Saudi
Arabian family. Within the family, there are three affected and
four unaffected members (Figure 1A). All affected members
of KKESH205 show typical LCA phenotypes, including lack
of  ERG,  infantile  nystagmus,  and  pigmentary  retinopathy
with a “rubelliform” appearance. In addition, several mild
phenotypes have been observed, including delayed walking
(after age 2), slowness in learning speech (after age 3 and 4),
and mild facial dysmorphism with bilateral enophthalmos.
Homozygosity mapping: To identify the causative mutation in
this family, we first performed direct Sanger sequencing to
check all the coding exons from all 15 known LCA disease
genes  in  one  affected  member  of  KKESH205.  No
homozygous  mutations  were  identified  within  the  coding
regions  of  these  15  genes  (data  not  shown).  Therefore,
homozygosity mapping of the disease locus was performed
by  genotyping  all  three  affected  members  of  KKESH205
using  the  Illumina  370K  SNP  array.  A  single  11.2  Mb
homozygous region on chromosome 15 is shared by all three
affected members, and therefore it almost certainly contains
the disease locus (Figure 1B). Consistent with the Sanger
sequencing described above, this region contains no known
LCA disease genes. Due to the high gene density in this
region, direct Sanger sequencing of all coding exons in this
11.2 Mb span was prohibitively expensive and labor intensive.
Mutation  detection:  Since  the  development  of  a  custom
designed regional capture is time-consuming and costly, we
decided to apply whole-exome capture sequencing to one
affected  individual  (KKESH205#7)  while  focusing  the
analysis  on  the  candidate  region  to  identify  the  disease-
causing mutation in this family. A total of about 1.6 million
reads uniquely map to the exons with an average of 18.6X
coverage. Moreover, 93% of targeted exons have at least 1X
coverage  (Figure  2).  Based  on  the  filtering  criteria  (see
Methods), a total of 370,000 SNPs and in/dels were identified
for further analysis. Since disease-causing variants for LCA
should be rare in the human population, common variants
were filtered out. Variants found in the Single Nucleotide
Polymorphism  database  (dbSNP  database)  or  the  1000
Genomes SNP database at frequency greater than 0.5% were
excluded, and the remaining variants are likely to be rare. As
expected, most variants (96.4%) identified in this individual
are indeed common. Finally, variants that did not lead to
coding changes (i.e., synonymous) were excluded. Based on
the current reference gene annotation, only variants that affect
protein  coding  changes  or  splicing  were  subject  to
downstream analysis. As a result, 352 candidate variants, all
of which are single nucleotide changes, were identified in the
entire exome (Appendix 1).
As described previously, homozygous mapping of this
consanguineous  KKESH205  family  via  high-density  SNP
genotyping  arrays  identified  a  single  critical  region  on
chromosome  15.  Inspection  of  the  352  candidate  variants
revealed only one homozygous missense change in this locus.
This missense mutation (G-C) is located in the fifth exon of
BBS4, a gene known to cause BBS, a rare human genetic
disorder  characterized  by  obesity,  retinal  dystrophy,  renal
anomalies,  hypogenitalism,  polydactyly,  and  numerous
developmental  and  behavioral  defects  [48].  As  ocular
phenotypes are a common clinical feature of BBS and LCA,
Molecular Vision 2011; 17:3529-3540 <http://www.molvis.org/molvis/v17/a379> © 2011 Molecular Vision
3531further analysis of this candidate mutation was performed.
First, this mutation was confirmed with Sanger sequencing
(Figure 3B). Second, segregation of this missense mutation in
BBS4 within this LCA family was examined. All members
from  KKESH205  were  genotyped  for  this  mutation  with
Sanger  sequencing;  as  expected,  this  allele  segregated
precisely with the disorder (Figure 3B). Third, to further test
if this mutation is indeed rare in the Saudi population, Sanger
sequencing was performed on 200 normal matching controls,
including 96 from Saudi Arabia. As expected, this mutation
was not observed in the control population, indicating that the
allele is rare. Furthermore, this mutation is not observed in the
dbSNP130 and 1,000 Genomes database, indicating that the
variant is very rare. This G->C mutation changes an amino
acid (Glutamate to Glutamine) that is conserved from lizard
to human (Figure 3C). A damage score of 4.91 was assigned
to  this  position  based  on  the  SeattleSNPs.  Since  loss  of
BBS4 function is known to cause BBS and BBS4 knockout
mice  show  severe  retinal  dystrophy,  this  novel  missense
mutation in BBS4 is likely to be pathologic in the KKESH205
family [49].
Functional study of the mutant allele: To further test if this
missense mutation negatively affects BBS4 gene function in
vivo, we used zebrafish, a model system well established for
assessing BBS gene function [42]. Suppression of cilia genes,
including  BBS4,  in  zebrafish  by  antisense  morpholinos
typically produce convergent-extension defects at the 12–14
cell  stage,  including  a  shortened  body  axis,  undulating
notochord,  and  broadened  somites  [44,50-53].  These
phenotypes likely reflect abnormal planar cell polarity (PCP)
signaling,  a  hypothesis  supported  by  evidence  that  BBS
proteins genetically and physically interact with components
of the PCP pathway [52,54,55]. Researchers have proposed
that defects in PCP signaling underlie some clinical features
of  BBS,  including  kidney  cysts  and  hearing  loss  [50,54].
Wild-type embryos (n=280–300) were injected at the 1–2 cell
stage with 4.0 ng of a bbs4 morpholino previously shown to
block  translation  of  bbs4  mRNA  [50].  Consistent  with
previous results, bbs4 morphants exhibited a shortened body
Figure  1.  Pedigree  and  homozygosity
mapping of KKESH205. A: Pedigree of
the  KKESH205  family  with  LCA  is
shown.  Affected,  solid  symbols;
unaffected,  open  symbols;  squares,
male; circles, female. B: Homozygosity
mapping  of  KKESH205  using  high-
density  SNP  arrays.  The  11.2  Mb
region, which is located on chromosome
15 (red box), is the only homozygous
region  shared  by  all  three  affected
members in the whole genome.
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3532axis (Figure 4A, red arrowheads), broadened somites, and a
kinked notochord (Figure 4A, red arrow) at the 12–14 somite
stage  (approximately  15  h  post-fertilization).  These
phenotypes were partially rescued by coinjection of wild-type
human  BBS4  mRNA  but  not  the  BBS4  missense  allele.
Overexpression  of  either  the  wild-type  or  mutant  BBS4
mRNA did not cause any phenotypes. Embryos with normal
somites  and  notochord  but  a  shortened  body  axis  were
considered  mild,  whereas  embryos  with  broad,  flattened
somites  and  severely  kinked  notochords  were  considered
severe.  Of  the  morpholino-injected  embryos,  59%  had  a
severe phenotype, and 89% exhibited some defect (Figure
4B). Severe phenotypes were seen in only 27% of the embryos
(n=80) when the bbs4 morpholino was coinjected with 150 pg
of wild-type human BBS4 mRNA and in only 19% of the
embryos (n=86) coinjected with 175 pg of wild-type BBS4
mRNA.  These  results  mirror  previous  reports  of
approximately 80% of morphants being rescued by human
wild-type BBS4 mRNA [50]. Importantly, injection of 200 pg
of  mRNA  from  the  human  BBS4  missense  allele  did  not
provide any rescuing effect (n=63). These results indicate that
the G253C allele is pathogenic and does not have any readily
apparent activity in this assay.
The clinical phenotypes associated with this BBS4 allele
prompted  us  to  investigate  whether  retinal  phenotypes  in
zebrafish were associated with morpholino suppression of
zebrafish bbs4. At 5 days post fertilization, zebrafish rod
photoreceptors express high levels of rhodopsin that localizes
almost  exclusively  to  the  photoreceptor  outer  segments
(Figure 4C). To test if bbs4 is involved in photoreceptors in
zebrafish,  retina  from  15  embryos  from  each  group  as
described above were sectioned and stained with rhodopsin.
Injection  of  bbs4  morpholinos  resulted  in  partial
mislocalization of rhodopsin to the inner segment. This result
resembles  the  Bbs4  knockout  mouse  [49,56],  where
photoreceptor  outer  segments  were  present  but  partial
rhodopsin  mislocalization  occurred  (Figure  4C,  white
arrows). When bbs4 morphants were coinjected with 200 ng
of human BBS4 mRNA, the trafficking defect was reversed,
and no rhodopsin mislocalization was observed. In contrast,
rhodopsin remained mislocalized in embryos coinjected with
morpholino and 200 ng of the BBS4 missense mRNA.
One  possible  mechanism  by  which  this  missense
mutation in BBS4 could cause a functional defect is to affect
protein  folding,  stability,  or  localization.  To  test  this
possibility, HeLa cells were transfected with wild-type or
mutant  full-length  BBS4  cDNA  in  the  expression  vector
pCmv-Tag1  (Stratagene,  La  Jolla,  CA).  BBS4  normally
localizes to the pericentriolar region of the cell and functions
in recruiting cargo to centriolar satellites [57]. In our study,
we found that wild-type endogenous BBS4 localizes to the
pericentriolar region of HeLa cells as described (Figure 5).
Similarly, the mutant BBS4 protein was also expressed and
localized to the pericentriolar region of the cell, suggesting
that the stable protein was produced and localized normally
(Figure 5).
DISCUSSION
Though the eye phenotype of LCA and BBS has some overlap,
they  are  still  slightly  different.  Patients  with  LCA  show
Figure  2.  Distribution  of  sequencing
coverage for the targeted region. A total
of about 1.6 million reads uniquely map
to the exons. Approximately 93% of the
coding exons from the targeted region
have at least 1X coverage.
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3533sensory nystagmus, amaurotic pupils, and absent electrical
signals on ERG. The BBS eye phenotype is called rod-cone
dystrophy, which means visual acuity, dark adaptation, and
peripheral visual fields are affected [58]. Patients with BBS
have attenuated light- and dark-adapted ERGs [59].
BBS4 comprises 16 exons, and at least 17 mutant alleles
have  been  reported,  including  nine  missense/nonsense
changes [60-63], three splicing changes [61] and five in/dels
(Figure 3A) [61-63]. BBS4 is a pericentriolar protein with a
key  role  in  recruiting  cargo  to  centriolar  satellites  and  is
required for microtubule anchoring and cell cycle progression
[57].  The  mechanism  by  which  this  new  allele  causes  a
phenotype  resembling  LCA  without  other  typical  defects
associated with BBS is likely due to a partial loss of function
that mainly affects the retinal function of BBS4. Based on our
cell  culture  assays,  this  mutation  does  not  affect  protein
production or localization. Therefore, loss of function is likely
due to either a retina-specific reduction of BBS4 protein levels
or a specific functional defect within the retina. The latter case
may  be  more  likely  since  overexpression  of  the  mutant
BBS4  allele  does  not  rescue  phenotypes  in  the  zebrafish
model. In mice, BBS4 is known to play an important role in
the proper transport of key phototransduction proteins from
photoreceptor inner segments to outer segments [49]. The new
allele we report here genetically separates BBS4 function in
the retina versus other tissues, and therefore provides a useful
reagent to specifically interrogate BBS4 function in retinal
dystrophy.
In  summary,  we  show  that  the  combination  of
homozygosity mapping, whole-exome enrichment, and next-
generation  sequencing  provides  a  sensitive,  accurate,  and
cost-efficient  tool  for  genetic  analysis.  Large  numbers  of
variants, including rare variants, exist in each individual. As
a result, although filtering against dbSNP and 1000 Genomes
data can dramatically reduce the number of variants, many
remain. Therefore, the main challenge of the whole exome
sequencing approach is to devise a strategy to dramatically
reduce the number of candidate variants for follow-up studies.
One  approach  is  to  take  advantage  of  genetic  mapping
information. In our case, homozygosity mapping narrowed
the candidate locus to an 11.2 Mb region. Intersection of
candidate variants and the candidate locus resulted in a single
remaining  variant.  In  addition,  high-throughput  functional
assays can be used to further test candidate genes. The small
Figure  3.  Gene  structure  of  human
BBS4.  A:  Exon-intron  structure  of
BBS4.  Exons  are  indicated  as  black
boxes.  The  single  missense  mutation
identified  is  located  in  the  fifth  exon
(p.E85Q, red arrow). B: Sequence traces
of  wild-type  and  affected  family
members.  A  homozygous  mutation
from G to C was identified in affected
member KKESH205#7 (red arrow). C:
Amino acid alignment of a portion of the
predicted  BBS4  protein  from  nine
different  vertebrate  species.  The
mutated  amino  acid  is  indicated
(p.E85Q, red arrow).
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3534Figure 4. BBS4 is required for normal zebrafish development and rhodopsin localization. A: Representative examples of whole-mounted wild-
type (WT) embryos, morpholino-injected (MO) embryos, embryos injected with wild-type (wt) or mutant (mut) human BBS4 mRNA, or
embryos coinjected with morpholino and mRNA. Dorsal view (top row) and lateral view (bottom row) are shown of embryos at the 12–14
somite stage following in situ hybridization with pax2a and myoD riboprobes. Embryos were categorized phenotypically based on shortened
body axis (anterior and posterior ends marked by red triangles) and notochord defects (red arrow). B: Quantification of the efficiency of rescue
from gastrulation defects following coinjection of BBS4 morpholino (MO) and mRNA. The number of animals analyzed for each group is
noted above each bar. C: Retinal cryosections of 5 dpf zebrafish retinas stained for rhodopsin (red). White arrows indicate rhodopsin
mislocalization (Scale bar=10 μm).
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3535size, high fecundity, and experimental tractability of zebrafish
make  it  an  excellent  system  for  cost-effective  and  rapid
screening of numerous candidates. Most human genes are
conserved in zebrafish, which can therefore serve as a valid
model  for  predicting  gene  function  in  humans.  The
combination of next-generation sequencing, genetic mapping,
and high-throughput functional assays will greatly accelerate
the identification of human disease genes.
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